##4080429
We	we	ppis2
conducted	conduct	vvd
a	a	at1
retrospective	retrospective	jj
study	study	nn1
to	to	to
evaluate	evaluate	vvi
the	the	at
clinicopathologic	clinicopathologic	jj
features	feature	nn2
and	and	cc
prognostic	prognostic	jj
factors	factor	nn2
associated	associate	vvn
with	with	iw
primary	primary	jj
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
.	.	y
We	we	ppis2
reviewed	review	vvd
the	the	at
records	record	nn2
of	of	io
10	10	mc
patients	patient	nn2
--		nn1_jj
7	7	mc
men	man	nn2
and	and	cc
3	3	mc
women	woman	nn2
,	,	y
aged	aged	ii
35	35	mc
to	to	ii
70	70	mc
years	year	nnt2
(	(	y
mean	mean	vv0
:	:	y
51.4	51.4	mc
)	)	y
--		nn1
who	who	pnqs
had	have	vhd
been	be	vbn
treated	treat	vvn
at	at	ii
our	our	appge
referral	referral	nn1
center	center	nn1
over	over	ii_rp
a	a	at1
9-year	9-year	jj_nnt1
period	period	nn1
.	.	y
The	the	at
tumors	tumor	nn2
were	be	vbdr
located	locate	vvn
in	in	ii
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
in	in	ii
7	7	mc
patients	patient	nn2
and	and	cc
in	in	ii
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
in	in	ii
the	the	at
other	other	jj_nn1@
3	3	mc
.	.	y
Medial	medial	jj
maxillectomy	maxillectomy	nn1
was	be	vbdz
performed	perform	vvn
in	in	ii
4	4	mc
patients	patient	nn2
,	,	y
wide	wide	jj_rr@
local	local	jj
excision	excision	nn1
in	in	ii
3	3	mc
,	,	y
and	and	cc
endoscopic	endoscopic	jj
excision	excision	nn1
in	in	ii
2	2	mc
;	;	y
the	the	at
remaining	remaining	jj
patient	patient	nn1_jj
,	,	y
who	who	pnqs
had	have	vhd
presented	present	vvn
with	with	iw
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
,	,	y
received	receive	vvd_jj@_vvn
chemotherapy	chemotherapy	nn1
and	and	cc
palliative	palliative	jj
local	local	jj
radiotherapy	radiotherapy	nn1
.	.	y
Two	two	mc
patients	patient	nn2
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
also	also	rr
underwent	undergo	vvd
concurrent	concurrent	jj
radical	radical	jj_nn1
neck	neck	nn1
dissection	dissection	nn1
.	.	y
Follow-up	follow-up	nn1
ranged	range	vvn_vvd
from	from	ii
8	8	mc
to	to	ii
70	70	mc
months	month	nnt2
(	(	y
median	median	nn1_jj
:	:	y
25	25	mc
)	)	y
.	.	y
Only	only	rr
4	4	mc
patients	patient	nn2
remained	remain	vvd_vvn
alive	alive	jj
through	through	ii
the	the	at
duration	duration	nn1
of	of	io
follow-up	follow-up	nn1_jj
.	.	y
The	the	at
2-	2-	nn1_jj
and	and	cc
5-year	5-year	jj
survival	survival	nn1
rates	rate	nn2
were	be	vbdr
60	60	mc
and	and	cc
40%	40%	nnu
,	,	y
respectively	respectively	rr
.	.	y
Based	base	vvn
on	on	ii
the	the	at
findings	finding	nn2
of	of	io
our	our	appge
small	small	jj
study	study	nn1
,	,	y
we	we	ppis2
conclude	conclude	vv0
that	that	cst_dd1
primary	primary	jj_nn1
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
carries	carry	vvz
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
cause	cause	nn1
of	of	io
death	death	nn1
in	in	ii
our	our	appge
series	series	nn
was	be	vbdz
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
(	(	y
n	xx_n	zz1
=	=	fo
5	5	mc
)	)	y
despite	despite	ii
adequate	adequate	jj
locoregional	loco-regional	jj
control	control	nn1
in	in	ii
most	most	dat
cases	case	nn2
.	.	y
This	this	dd1
finding	finding	nn1
confirms	confirm	vvz
the	the	at
aggressive	aggressive	jj
nature	nature	nn1
of	of	io
this	this	dd1
disease	disease	nn1
.	.	y
Other	other	jj
factors	factor	nn2
that	that	cst
appeared	appear	vvd
to	to	to
be	be	vbi
associated	associate	vvn
with	with	iw
a	a	at1
poor	poor	jj
prognosis	prognosis	nn1
were	be	vbdr
(	(	y
1	1	mc1
)	)	y
older	old	jjr
age	age	nn1
,	,	y
(	(	y
2	2	mc
)	)	y
a	a	at1
primary	primary	jj_nn1
tumor	tumor	nn1
location	location	nn1
in	in	ii
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
,	,	y
(	(	y
3	3	mc
)	)	y
an	a	at1
advanced	advanced	jj
tumor	tumor	nn1
stage	stage	nn1
,	,	y
(	(	y
4	4	mc
)	)	y
an	a	at1
external	external	jj
approach	approach	nn1
to	to	ii
surgery	surgery	nn1
,	,	y
and	and	cc
(	(	y
5	5	mc
)	)	y
the	the	at
absence	absence	nn1
of	of	io
adjuvant	adjuvant	jj_nn1
radiotherapy	radiotherapy	nn1
.	.	y
Mucosal	mucosal	jj
melanomas	melanoma	nn2
were	be	vbdr
first	first	md
described	describe	vvn
by	by	ii
Weber	weber	np1
in	in	ii
1859.	1859	mc
n1	n1	fo
Primary	primary	jj_nn1
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
is	be	vbz
a	a	at1
rare	rare	jj
lesion	lesion	nn1
,	,	y
with	with	iw
a	a	at1
reported	reported	jj@
annual	annual	jj
incidence	incidence	nn1
of	of	io
0.018	0.018	mc
per	per	ii
100,000	100,000	mc
population.	population	nnu
n2	n2	fo
Mucosal	mucosal	jj
malignant	malignant	jj_nn1
melanoma	melanoma	nn1
has	have	vhz
a	a	at1
different	different	jj
clinical	clinical	jj
course	course	nn1
and	and	cc
outcome	outcome	nn1
than	than	csn
its	its	z'
cutaneous	cutaneous	jj
counterpart	counterpart	nn1
.	.	y
Sinonasal	sinonasal	nn1_jj@_np1@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
,	,	y
in	in	ii
turn	turn	nn1
,	,	y
has	have	vhz
a	a	at1
different	different	jj
clinical	clinical	jj
course	course	nn1
and	and	cc
outcome	outcome	nn1
than	than	csn
malignant	malignant	jj
melanoma	melanoma	nn1
in	in	ii
other	other	jj
mucosal	mucosal	jj
sites.	sites	nnu
(	(	y
n3-n5	n3-n5	nn1_jj
)	)	y
For	for	rex21
example	example	rex22
,	,	y
sinonasal	sinonasal	jj@_nn1
malignant	malignant	jj_nn1
melanoma	melanoma	nn1
has	have	vhz
a	a	at1
more	more	rgr
aggressive	aggressive	jj
behavior	behavior	nn1
and	and	cc
is	be	vbz
associated	associate	vvn
with	with	iw
a	a	at1
poorer	poor	jjr
prognosis	prognosis	nn1
than	than	csn
oral	oral	jj
cavity	cavity	nn1
melanoma	melanoma	nn1
despite	despite	ii
aggressive	aggressive	jj
surgical	surgical	jj
treatment	treatment	nn1
and	and	cc
postoperative	postoperative	jj
irradiation	irradiation	nn1
.	.	y
The	the	at
poorer	poor	jjr
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
.	.	y
The	the	at
relative	relative	jj_nn1
inaccessibility	inaccessibility	nn1
of	of	io
the	the	at
mucosa	mucosa	nn1
to	to	ii
self-examination	self-examination	nn1_jj
often	often	rr
delays	delay	nn2_vvz%
diagnosis	diagnosis	nn1
.	.	y
Also	also	rr
,	,	y
morbidity	morbidity	nn1
and	and	cc
mortality	mortality	nn1
may	may	vm
be	be	vbi
increased	increase	vvn
as	as	ii
a	a	at1
result	result	nn1
of	of	io
the	the	at
proximity	proximity	nn1
of	of	io
these	these	dd2
tumors	tumor	nn2
to	to	ii
vital	vital	jj
structures	structure	nn2
such	such	ii21
as	as	ii22
the	the	at
orbit	orbit	nn1
and	and	cc
brain	brain	nn1
.	.	y
The	the	at
differential	differential	jj_nn1
diagnosis	diagnosis	nn1
should	should	vm
include	include	vvi
carcinoma	carcinoma	nn1
,	,	y
lymphoma	lymphoma	nn1
,	,	y
Sarcoma	sarcoma	np1
,	,	y
and	and	cc
olfactory	olfactory	jj
neuroblastoma	neuroblastoma	nn1
.	.	y
Because	because	ii21
of	of	ii22
the	the	at
small	small	jj
number	number	nn1
of	of	io
primary	primary	jj_nn1
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanomas	melanoma	nn2
that	that	cst
have	have	vh0
been	be	vbn
reported	report	vvn
in	in	ii
the	the	at
literature	literature	nn1
,	,	y
little	little	rr_da1_jj
new	new	jj
information	information	nn1
has	have	vhz
been	be	vbn
generated	generate	vvn
about	about	ii
this	this	dd1
entity	entity	nn1
,	,	y
and	and	cc
treatments	treatment	nn2
have	have	vh0
varied	vary	vvn
over	over	ii_rp
the	the	at
years	year	nnt2
.	.	y
In	in	ii
this	this	dd1
article	article	nn1
,	,	y
we	we	ppis2
describe	describe	vv0
our	our	appge
retrospective	retrospective	jj
study	study	nn1
of	of	io
the	the	at
clinicopathologic	clinicopathologic	jj
features	feature	nn2
of	of	io
and	and	cc
prognostic	prognostic	jj
factors	factor	nn2
associated	associate	vvn
with	with	iw
cases	case	nn2
of	of	io
primary	primary	jj_nn1
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
that	that	cst
were	be	vbdr
managed	manage	vvn
at	at	ii
our	our	appge
institution	institution	nn1
.	.	y
Patients	patient	nn2
and	and	cc
methods	method	nn2
We	we	ppis2
reviewed	review	vvd
the	the	at
medical	medical	jj
records	record	nn2
of	of	io
all	all	db
patients	patient	nn2
who	who	pnqs
had	have	vhd
been	be	vbn
treated	treat	vvn
for	for	if
primary	primary	jj_nn1
head	head	nn1
and	and	cc
neck	neck	nn1_vv0@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
at	at	ii
our	our	appge
institution	institution	nn1
between	between	ii
January	january	npm1
1996	1996	mc
and	and	cc
December	december	npm1
2004	2004	mc
.	.	y
We	we	ppis2
found	find	vvd
90	90	mc
such	such	da
cases	case	nn2
.	.	y
All	all	db
patients	patient	nn2
had	have	vhd
undergone	undergo	vvn
clinical	clinical	jj
examination	examination	nn1
of	of	io
the	the	at
neck	neck	nn1
and	and	cc
abdomen	abdomen	nn1
,	,	y
nasal	nasal	jj
endoscopy	endoscopy	nn1
to	to	to
determine	determine	vvi
the	the	at
extent	extent	nn1
of	of	io
the	the	at
tumor	tumor	nn1
,	,	y
and	and	cc
contrast-enhanced	contrast-enhanced	jj_nn1
computed	computed	jj@_vvd_vvn
tomography	tomography	nn1
of	of	io
the	the	at
nose	nose	nn1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
been	be	vbn
performed	perform	vvn
in	in	ii
those	those	dd2
patients	patient	nn2
who	who	pnqs
had	have	vhd
been	be	vbn
suspected	suspect	vvn
of	of	io
having	have	vhg
intracranial	intracranial	jj
extension	extension	nn1
.	.	y
All	all	db
patients	patient	nn2
had	have	vhd
undergone	undergo	vvn
ultrasonography	ultrasonography	nn1
of	of	io
the	the	at
abdomen	abdomen	nn1
and	and	cc
a	a	at1
bone	bone	nn1
scan	scan	nn1_vv0
to	to	to
look	look	vvi
for	for	if
distant	distant	jj
metastases	metastasis	nn2
.	.	y
We	we	ppis2
then	then	rt
narrowed	narrow	vvd
our	our	appge
population	population	nn1
to	to	ii
those	those	dd2
who	who	pnqs
had	have	vhd
presented	present	vvn
with	with	iw
a	a	at1
primary	primary	jj
malignant	malignant	jj_nn1
melanoma	melanoma	nn1
of	of	io
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
or	or	cc
paranasal	paranasal	nn1_jj@
sinuses	sinus	nn2_vvz
.	.	y
Patients	patient	nn2
with	with	iw
ocular	ocular	jj
melanoma	melanoma	nn1
that	that	cst
had	have	vhd
extended	extend	vvn
into	into	ii
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
were	be	vbdr
not	not	xx
included	include	vvn
in	in	ii
our	our	appge
analysis	analysis	nn1
.	.	y
The	the	at
primary	primary	jj_nn1
nature	nature	nn1
of	of	io
the	the	at
presenting	presenting	nn1@_vvg
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
had	have	vhd
been	be	vbn
confirmed	confirm	vvn
by	by	ii
clinical	clinical	jj
data	data	nn
--		nn1_jj
specifically	specifically	rr
,	,	y
(	(	y
1	1	mc1
)	)	y
the	the	at
absence	absence	nn1
of	of	io
a	a	at1
history	history	nn1
of	of	io
melanoma	melanoma	nn1
at	at	ii
any	any	dd
other	other	jj
site	site	nn1
in	in	ii
the	the	at
body	body	nn1
and	and	cc
(	(	y
2	2	mc
)	)	y
an	a	at1
absence	absence	nn1
of	of	io
evidence	evidence	nn1
of	of	io
a	a	at1
metastatic	metastatic	jj
melanoma	melanoma	nn1
from	from	ii
an	a	at1
extramucosal	extramucosal	nn1_jj@
site	site	nn1
.	.	y
In	in	ii
all	all	db
,	,	y
10	10	mc
patients	patient	nn2
--		nn1_jj
7	7	mc
men	man	nn2
and	and	cc
3	3	mc
women	woman	nn2
,	,	y
aged	aged	ii
35	35	mc
to	to	ii
70	70	mc
years	year	nnt2
(	(	y
mean	mean	vv0
:	:	y
51.4	51.4	mc
)	)	y
--		nn1
met	meet	vvd_vvn
our	our	appge
inclusion	inclusion	nn1
criteria	criteria	nn2
.	.	y
In	in	ii31
addition	addition	ii32
to	to	ii33
demographic	demographic	jj
data	data	nn
,	,	y
we	we	ppis2
compiled	compile	vvd
information	information	nn1
on	on	ii
presenting	present	vvg
symptoms	symptom	nn2
,	,	y
the	the	at
site	site	nn1
of	of	io
the	the	at
primary	primary	jj_nn1
tumor	tumor	nn1
,	,	y
the	the	at
presence	presence	nn1
of	of	io
any	any	dd
nodal	nodal	jj
or	or	cc
distant	distant	jj
metastasis	metastasis	nn1
at	at	ii
presentation	presentation	nn1
,	,	y
the	the	at
tumor	tumor	nn1
stage	stage	nn1
,	,	y
initial	initial	jj_nn1
treatment	treatment	nn1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
and	and	cc
its	its	z'
treatment	treatment	nn1
,	,	y
outcomes	outcome	nn2
,	,	y
and	and	cc
histopathologic	histopathologic	jj
features	feature	nn2
.	.	y
Presenting	present	vvg
features	feature	nn2
.	.	y
The	the	at
presenting	presenting	nn1@_vvg
symptoms	symptom	nn2
were	be	vbdr
nasal	nasal	jj
obstruction	obstruction	nn1
in	in	ii
6	6	mc
patients	patient	nn2
,	,	y
epistaxis	epistaxis	nn1
in	in	ii
2	2	mc
,	,	y
epiphora	epiphora	nn1
in	in	ii
2	2	mc
,	,	y
neck	neck	nn1_vv0@
swelling	swell	vvg
in	in	ii
2	2	mc
,	,	y
and	and	cc
diplopia	diplopia	nn1
with	with	iw
a	a	at1
decrease	decrease	nn1
in	in	ii
vision	vision	nn1
in	in	ii
1	1	mc1
.	.	y
The	the	at
primary	primary	jj_nn1
tumor	tumor	nn1
was	be	vbdz
seen	see	vvn
in	in	ii
the	the	at
nasal	nasal	jj
cavity	cavity	nn1
in	in	ii
7	7	mc
patients	patient	nn2
and	and	cc
in	in	ii
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
in	in	ii
3	3	mc
(	(	y
2	2	mc
maxillary	maxillary	jj
sinus	sinus	nn1
and	and	cc
1	1	mc1
ethmoid	ethmoid	jj_nn1
sinus	sinus	nn1
)	)	y
.	.	y
Two	two	mc
patients	patient	nn2
presented	present	vvn_vvd
with	with	iw
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
and	and	cc
1	1	mc1
with	with	iw
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
.	.	y
Six	six	mc
patients	patient	nn2
had	have	vhd
a	a	at1
clinical	clinical	jj
stage	stage	nn1
I	i	mc1%
tumor	tumor	nn1
,	,	y
2	2	mc
had	have	vhd
a	a	at1
stage	stage	nn1
II	ii	mc
tumor	tumor	nn1
,	,	y
and	and	cc
1	1	mc1
patient	patient	nn1_jj
each	each	dd1
had	have	vhd
a	a	at1
stage	stage	nn1
III	iii	mc
and	and	cc
IV	iv	mc_jj%
tumor	tumor	nn1
(	(	y
table	table	nn1
)	)	y
.	.	y
Initial	initial	jj_nn1
treatment	treatment	nn1
.	.	y
Nine	nine	mc
patients	patient	nn2
had	have	vhd
undergone	undergo	vvn
surgical	surgical	jj
excision	excision	nn1
of	of	io
the	the	at
primary	primary	jj_nn1
tumor	tumor	nn1
--		nn1
7	7	mc
via	via	ii
an	a	at1
external	external	jj
approach	approach	nn1
and	and	cc
2	2	mc
via	via	ii
an	a	at1
endoscopic	endoscopic	jj
approach	approach	nn1
.	.	y
The	the	at
remaining	remaining	jj
patient	patient	nn1
(	(	y
patient	patient	nn1_jj
5	5	mc
)	)	y
,	,	y
who	who	pnqs
had	have	vhd
presented	present	vvn
with	with	iw
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
,	,	y
received	receive	vvd_jj@_vvn
chemotherapy	chemotherapy	nn1
and	and	cc
palliative	palliative	jj
local	local	jj
radiotherapy	radiotherapy	nn1
.	.	y
The	the	at
7	7	mc
external	external	jj
procedures	procedure	nn2
included	include	vvd_vvn
a	a	at1
medial	medial	jj
maxillectomy	maxillectomy	nn1
in	in	ii
4	4	mc
patients	patient	nn2
and	and	cc
wide	wide	jj_rr@
local	local	jj
excision	excision	nn1
in	in	ii
3	3	mc
patients	patient	nn2
(	(	y
table	table	nn1
)	)	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
at	at	ii
presentation	presentation	nn1
also	also	rr
underwent	undergo	vvd
neck	neck	nn1
dissection	dissection	nn1
concurrently	concurrently	rr
with	with	iw
excision	excision	nn1
of	of	io
the	the	at
primary	primary	jj_nn1
tumor	tumor	nn1
.	.	y
Follow-up	follow-up	nn1_jj
.	.	y
Patients	patient	nn2
were	be	vbdr
kept	keep	vvn
on	on	ii
a	a	at1
regular	regular	jj
follow-up	follow-up	jj_nn1
schedule	schedule	nn1
after	after	ii_cs
treatment	treatment	nn1
.	.	y
Follow-up	follow-up	nn1
ranged	range	vvn_vvd
from	from	ii
8	8	mc
to	to	ii
70	70	mc
months	month	nnt2
(	(	y
median	median	nn1_jj
:	:	y
25	25	mc
)	)	y
(	(	y
table	table	nn1
)	)	y
.	.	y
Total	total	jj_nn1
follow-up	follow-up	nn1
was	be	vbdz
calculated	calculate	vvn
in	in	ii
months	month	nnt2
from	from	ii
the	the	at
date	date	nn1
of	of	io
diagnosis	diagnosis	nn1
to	to	ii
the	the	at
last	last	md
recorded	recorded	jj@_vvd_vvn
encounter	encounter	nn1
.	.	y
Sequelae	sequelae	nn2_np1@
.	.	y
Following	follow	vvg_ii@_jj@
initial	initial	jj_nn1
surgery	surgery	nn1
,	,	y
3	3	mc
patients	patient	nn2
developed	develop	vvd_vvn
a	a	at1
local	local	jj
recurrence	recurrence	nn1
,	,	y
2	2	mc
developed	develop	vvd_vvn
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
,	,	y
and	and	cc
4	4	mc
developed	develop	vvd_vvn
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
(	(	y
2	2	mc
lung	lung	nn1
,	,	y
1	1	mc1
spinal	spinal	jj
cord	cord	nn1
,	,	y
and	and	cc
1	1	mc1
liver	liver	nn1
)	)	y
.	.	y
The	the	at
local	local	jj
recurrences	recurrence	nn2
were	be	vbdr
treated	treat	vvn
with	with	iw
endoscopic	endoscopic	jj
and	and	cc
wide	wide	jj
excision	excision	nn1
,	,	y
the	the	at
neck	neck	nn1
node	node	nn1
metastases	metastases	vvz_nn2
with	with	iw
neck	neck	nn1
dissection	dissection	nn1
,	,	y
and	and	cc
the	the	at
distant	distant	jj
metastases	metastasis	nn2
with	with	iw
chemotherapy	chemotherapy	nn1
.	.	y
In	in	ii31
addition	addition	ii32
to	to	ii33
the	the	at
1	1	mc1
patient	patient	nn1
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
and	and	cc
who	who	pnqs
received	receive	vvd
palliative	palliative	jj
local	local	jj
radiotherapy	radiotherapy	nn1
(	(	y
patient	patient	nn1_jj
5	5	mc
)	)	y
,	,	y
6	6	mc
patients	patient	nn2
received	receive	vvd_vvn
postoperative	postoperative	jj
radiotherapy	radiotherapy	nn1
--		nn1
3	3	mc
for	for	if
a	a	at1
local	local	jj
recurrence	recurrence	nn1
,	,	y
2	2	mc
for	for	if
a	a	at1
nodal	nodal	jj
metastasis	metastasis	nn1
,	,	y
and	and	cc
1	1	mc1
for	for	if
a	a	at1
spinal	spinal	jj
cord	cord	nn1
metastasis	metastasis	nn1
.	.	y
In	in	ii31
addition	addition	ii32
to	to	ii33
patient	patient	nn1_jj
5	5	mc
,	,	y
3	3	mc
patients	patient	nn2
received	receive	vvd_vvn
postoperative	postoperative	jj
chemotherapy	chemotherapy	nn1
with	with	iw
dacarbazine	dacarbazine	nn1
for	for	if
the	the	at
treatment	treatment	nn1
of	of	io
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
1	1	mc1
for	for	if
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
.	.	y
The	the	at
patient	patient	nn1
who	who	pnqs
developed	develop	vvd
a	a	at1
spinal	spinal	jj
cord	cord	nn1
metastasis	metastasis	nn1
(	(	y
patient	patient	nn1_jj
3	3	mc
)	)	y
did	do	vdd
not	not	xx
receive	receive	vvi
chemotherapy	chemotherapy	nn1
.	.	y
Results	result	nn2
At	at	ii
the	the	at
final	final	jj_nn1
follow-up	follow-up	nn1_jj
,	,	y
4	4	mc
of	of	io
the	the	at
10	10	mc
patients	patient	nn2
were	be	vbdr
alive	alive	jj
and	and	cc
without	without	iw
disease	disease	nn1
(	(	y
table	table	nn1
)	)	y
.	.	y
Overall	overall	jj_rr
2-	2-	nn1_jj
and	and	cc
5-year	5-year	jj
survival	survival	nn1
rates	rate	nn2
were	be	vbdr
60	60	mc
and	and	cc
40%	40%	nnu
,	,	y
respectively	respectively	rr
.	.	y
The	the	at
4	4	mc
survivors	survivor	nn2
at	at	ii
the	the	at
last	last	md
follow-up	follow-up	jj_nn1
--		nn1
3	3	mc
men	man	nn2
and	and	cc
1	1	mc1
woman	woman	nn1
--		nn1
ranged	range	vvn_vvd
in	in	ii
age	age	nn1
from	from	ii
35	35	mc
to	to	ii
60	60	mc
years	year	nnt2
(	(	y
mean	mean	vv0
:	:	y
47.0	47.0	mc
)	)	y
.	.	y
The	the	at
6	6	mc
patients	patient	nn2
who	who	pnqs
died	die	vvd
included	include	vvn_vvd
4	4	mc
men	man	nn2
and	and	cc
2	2	mc
women	woman	nn2
;	;	y
their	their	appge
ages	age	nn2
ranged	range	vvn_vvd
from	from	ii
41	41	mc
to	to	ii
70	70	mc
years	year	nnt2
(	(	y
mean	mean	vv0
:	:	y
54.3	54.3	mc
)	)	y
Presenting	present	vvg
features	feature	nn2
.	.	y
Two	two	mc
of	of	io
the	the	at
3	3	mc
patients	patient	nn2
(	(	y
67%	67%	nnu
)	)	y
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
melanoma	melanoma	nn1
died	die	vvd
,	,	y
compared	compare	vvn
with	with	iw
4	4	mc
of	of	io
7	7	mc
patients	patient	nn2
(	(	y
57%	57%	nnu
)	)	y
who	who	pnqs
had	have	vhd
a	a	at1
primary	primary	jj
nasal	nasal	jj
cavity	cavity	nn1
tumor	tumor	nn1
.	.	y
Of	of	io
the	the	at
2	2	mc
patients	patient	nn2
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
,	,	y
1	1	mc1
was	be	vbdz
alive	alive	jj
at	at	ii
36	36	mc
months	month	nnt2
.	.	y
The	the	at
other	others	nn1@_jj
developed	develop	vvd_vvn
a	a	at1
spinal	spinal	jj
cord	cord	nn1
metastasis	metastasis	nn1
postoperatively	postoperatively	rr
,	,	y
and	and	cc
he	he	pphs1
died	die	vvd
12	12	mc
months	month	nnt2
after	after	ii_cs
diagnosis	diagnosis	nn1
.	.	y
The	the	at
patient	patient	nn1
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
died	die	vvd
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
presented	present	vvd
with	with	iw
a	a	at1
stage	stage	nn1
I	i	mc1%
tumor	tumor	nn1
and	and	cc
1	1	mc1
of	of	io
the	the	at
2	2	mc
who	who	pnqs
presented	present	vvd
with	with	iw
a	a	at1
stage	stage	nn1
II	ii	mc
tumor	tumor	nn1
were	be	vbdr
still	still	rr
alive	alive	jj
by	by	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
.	.	y
In	in	ii
contrast	contrast	nn1
,	,	y
the	the	at
patients	patient	nn2
with	with	iw
stage	stage	nn1
III	iii	mc
and	and	cc
stage	stage	nn1
IV	iv	mc
disease	disease	nn1
both	both	rr
died	die	vvd
8	8	mc
months	month	nnt2
after	after	ii_cs
diagnosis	diagnosis	nn1
.	.	y
Initial	initial	jj_nn1
treatment	treatment	nn1
.	.	y
Three	three	mc
of	of	io
the	the	at
4	4	mc
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
medial	medial	jj
maxillectomy	maxillectomy	nn1
survived	survive	vvd_vvn@
to	to	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
.	.	y
However	however	rr
,	,	y
2	2	mc
of	of	io
the	the	at
survivors	survivor	nn2
subsequently	subsequently	rr
developed	develop	vvn_vvd
a	a	at1
local	local	jj
recurrence	recurrence	nn1
and	and	cc
1	1	mc1
developed	develop	vvd_vvn
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
.	.	y
The	the	at
patient	patient	nn1
who	who	pnqs
died	die	vvd
had	have	vhd
a	a	at1
liver	liver	nn1
metastasis	metastasis	nn1
.	.	y
Of	of	io
the	the	at
2	2	mc
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
endoscopic	endoscopic	jj
excision	excision	nn1
,	,	y
1	1	mc1
died	die	vvd_vvn@
at	at	ii
12	12	mc
months	month	nnt2
of	of	io
a	a	at1
spinal	spinal	jj
cord	cord	nn1
metastasis	metastasis	nn1
,	,	y
and	and	cc
1	1	mc1
was	be	vbdz
alive	alive	jj
at	at	ii
70	70	mc
months	month	nnt2
.	.	y
However	however	rr
,	,	y
the	the	at
survivor	survivor	nn1
did	do	vdd
develop	develop	vvi
a	a	at1
postoperative	postoperative	jj
local	local	jj
recurrence	recurrence	nn1
.	.	y
None	none	pn
of	of	io
the	the	at
3	3	mc
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
wide	wide	jj_rr@
local	local	jj
excision	excision	nn1
survived	survive	vvd
.	.	y
One	one	pn1
developed	develop	vvd_vvn
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
and	and	cc
died	die	vvd
at	at	ii
30	30	mc
months	month	nnt2
,	,	y
and	and	cc
2	2	mc
developed	develop	vvd_vvn
a	a	at1
lung	lung	nn1
metastasis	metastasis	nn1
and	and	cc
died	die	vvd
at	at	ii
8	8	mc
and	and	cc
26	26	mc
months	month	nnt2
.	.	y
Sequelae	sequelae	nn2_np1@
.	.	y
All	all	db
3	3	mc
patients	patient	nn2
who	who	pnqs
developed	develop	vvd
a	a	at1
postoperative	postoperative	jj
local	local	jj
recurrence	recurrence	nn1
were	be	vbdr
alive	alive	jj
at	at	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
.	.	y
Of	of	io
the	the	at
2	2	mc
patients	patient	nn2
who	who	pnqs
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
at	at	ii
24	24	mc
months	month	nnt2
and	and	cc
the	the	at
other	others	nn1@_jj
died	die	vvd_vvn@
at	at	ii
30	30	mc
months	month	nnt2
.	.	y
All	all	db
4	4	mc
patients	patient	nn2
who	who	pnqs
developed	develop	vvd
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
postoperatively	postoperatively	rr
died	die	vvd_vvn@
within	within	ii
26	26	mc
months	month	nnt2
of	of	io
diagnosis	diagnosis	nn1
(	(	y
mean	mean	vv0
:	:	y
15	15	mc
;	;	y
median	median	nn1_jj
13	13	mc
)	)	y
.	.	y
Radiotherapy	radiotherapy	nn1_np1@
.	.	y
Of	of	io
the	the	at
5	5	mc
patients	patient	nn2
who	who	pnqs
had	have	vhd
received	receive	vvn
a	a	at1
radical	radical	jj_nn1
dose	dose	nn1
of	of	io
radiation	radiation	nn1
(	(	y
50	50	mc
Gy	gy	np1_jj_nn1
)	)	y
,	,	y
4	4	mc
were	be	vbdr
alive	alive	jj
at	at	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
.	.	y
Patient	patient	nn1_jj
3	3	mc
received	receive	vvd_vvn
only	only	rr
30	30	mc
Gy	gy	jj_np1_nn1
.	.	y
Chemotherapy	chemotherapy	nn1
.	.	y
All	all	db
4	4	mc
patients	patient	nn2
who	who	pnqs
received	receive	vvd
chemotherapy	chemotherapy	nn1
died	die	vvd_vvn@
within	within	ii
26	26	mc
months	month	nnt2
(	(	y
mean	mean	vv0
:	:	y
14	14	mc
)	)	y
.	.	y
Histopathology	histopathology	nn1_np1@
.	.	y
There	there	ex
was	be	vbdz
a	a	at1
considerable	considerable	jj
difference	difference	nn1
in	in	ii
the	the	at
number	number	nn1
of	of	io
diseased	diseased	jj
neck	neck	nn1
nodes	node	nn2
seen	see	vvn
on	on	ii
histopathology	histopathology	nn1
(	(	y
range	range	nn1_vv0@
:	:	y
10	10	mc
to	to	ii
20	20	mc
;	;	y
mean	mean	vv0
:	:	y
15	15	mc
)	)	y
compared	compare	vvn_vvd@
with	with	iw
the	the	at
number	number	nn1
detected	detect	vvn_vvd
on	on	ii
palpation	palpation	nn1
(	(	y
mean	mean	vv0
:	:	y
2	2	mc
)	)	y
.	.	y
Discussion	discussion	nn1
The	the	at
5-year	5-year	jj_nnt1
survival	survival	nn1
rate	rate	nn1
of	of	io
40%	40%	nnu
in	in	ii
our	our	appge
study	study	nn1
is	be	vbz
comparable	comparable	jj
to	to	ii
the	the	at
rates	rate	nn2
in	in	ii
studies	study	nn2
reported	report	vvn
by	by	ii
Snow	snow	np1
et	et	ra21
al	al	ra22
n6	n6	fo
(	(	y
38%	38%	nnu
)	)	y
and	and	cc
Manolidis	manolidis	np1
and	and	cc
Donald	donald	np1
n7	n7	fo
(	(	y
30%	30%	nnu
)	)	y
.	.	y
The	the	at
primary	primary	jj_nn1
indicator	indicator	nn1
of	of	io
a	a	at1
poor	poor	jj
prognosis	prognosis	nn1
in	in	ii
our	our	appge
study	study	nn1
was	be	vbdz
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
.	.	y
All	all	db
5	5	mc
patients	patient	nn2
with	with	iw
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
died	die	vvd_vvn@
within	within	ii
26	26	mc
months	month	nnt2
despite	despite	ii
adequate	adequate	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
aggressive	aggressive	jj
nature	nature	nn1
of	of	io
this	this	dd1
disease	disease	nn1
.	.	y
None	none	pn
of	of	io
the	the	at
4	4	mc
survivors	survivor	nn2
had	have	vhd
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
,	,	y
and	and	cc
only	only	rr
1	1	mc1
patient	patient	nn1_jj
without	without	iw
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
had	have	vhd
died	die	vvn
during	during	ii
follow-up	follow-up	nn1_jj
.	.	y
Other	other	jj_nn1@
possibly	possibly	rr
poor	poor	jj
prognostic	prognostic	jj
factors	factor	nn2
included	include	vvn_vvd
(	(	y
1	1	mc1
)	)	y
older	old	jjr
age	age	nn1
,	,	y
(	(	y
2	2	mc
)	)	y
a	a	at1
primary	primary	jj_nn1
tumor	tumor	nn1
location	location	nn1
in	in	ii
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
,	,	y
(	(	y
3	3	mc
)	)	y
an	a	at1
advanced	advanced	jj
tumor	tumor	nn1
stage	stage	nn1
,	,	y
(	(	y
4	4	mc
)	)	y
an	a	at1
external	external	jj
approach	approach	nn1
to	to	ii
surgery	surgery	nn1
,	,	y
and	and	cc
(	(	y
5	5	mc
)	)	y
the	the	at
absence	absence	nn1
of	of	io
adjuvant	adjuvant	jj_nn1
radiotherapy	radiotherapy	nn1
.	.	y
The	the	at
mean	mean	jj
age	age	nn1
of	of	io
the	the	at
patients	patient	nn2
in	in	ii
our	our	appge
study	study	nn1
(	(	y
51.4	51.4	mc
yr	yr	nnu
)	)	y
is	be	vbz
consistent	consistent	jj
with	with	iw
that	that	dd1
reported	report	vvd_vvn
by	by	ii
others	others	nn2
in	in	ii
the	the	at
literature.	literature	nnu
(	(	y
n8	n8	fo
,	,	y
n9	n9	fo
)	)	y
Also	also	rr
,	,	y
the	the	at
male	male	jj_nn1
preponderance	preponderance	nn1
and	and	cc
the	the	at
disease	disease	nn1
predilection	predilection	nn1
for	for	if
patients	patient	nn2
older	old	jjr
than	than	csn
50	50	mc
years	year	nnt2
(	(	y
n	xx_n	zz1
=	=	fo
7	7	mc
)	)	y
in	in	ii
our	our	appge
study	study	nn1
population	population	nn1
has	have	vhz
been	be	vbn
noted	note	vvn
in	in	ii
other	other	jj
series.	series	nnu
(	(	y
n10	n10	fo
,	,	y
n11	n11	fo
)	)	y
For	for	if
many	many	da2
reasons	reason	nn2
,	,	y
including	including	ii_vvg@
better	better	jjr
immunosurveillance	immunosurveillance	nn1
and	and	cc
a	a	at1
less	less	rgr
virulent	virulent	jj
form	form	nn1
of	of	io
melanoma	melanoma	nn1
,	,	y
younger	young	jjr
patients	patient	nn2
generally	generally	rr
have	have	vh0
a	a	at1
better	better	jjr
prognosis	prognosis	nn1
.	.	y
The	the	at
site	site	nn1
of	of	io
the	the	at
primary	primary	jj_nn1
tumor	tumor	nn1
might	might	vm
also	also	rr
have	have	vhi
been	be	vbn
a	a	at1
prognostic	prognostic	jj
factor	factor	nn1
,	,	y
as	as	csa_rg@
67%	67%	nnu
of	of	io
those	those	dd2
with	with	iw
a	a	at1
paranasal	paranasal	nn1_jj@
sinus	sinus	nn1
melanoma	melanoma	nn1
died	die	vvd
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
tumor	tumor	nn1
.	.	y
The	the	at
expected	expected	jj
association	association	nn1
between	between	ii
tumor	tumor	nn1
stage	stage	nn1
at	at	ii
diagnosis	diagnosis	nn1
and	and	cc
outcomes	outcome	nn2
was	be	vbdz
seen	see	vvn
in	in	ii
our	our	appge
study	study	nn1
.	.	y
In	in	ii
all	all	db
,	,	y
4	4	mc
patients	patient	nn2
experienced	experience	vvd_vvn
a	a	at1
neck	neck	nn1
node	node	nn1
metastasis	metastasis	nn1
.	.	y
Two	two	mc
of	of	io
these	these	dd2
were	be	vbdr
present	present	jj_nn1
at	at	ii
diagnosis	diagnosis	nn1
,	,	y
and	and	cc
2	2	mc
others	others	nn2
occurred	occur	vvd
postoperatively	postoperatively	rr
.	.	y
In	in	ii
both	both	db2
circumstances	circumstance	nn2
,	,	y
1	1	mc1
patient	patient	nn1
died	die	vvd_vvn@
during	during	ii
follow-up	follow-up	nn1_jj
and	and	cc
1	1	mc1
remained	remain	vvd_vvn
alive	alive	jj
at	at	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
(	(	y
table	table	nn1
)	)	y
.	.	y
Of	of	io
the	the	at
2	2	mc
patients	patient	nn2
who	who	pnqs
underwent	undergo	vvd
endoscopic	endoscopic	jj
excision	excision	nn1
,	,	y
1	1	mc1
experienced	experience	vvd_vvn
a	a	at1
recurrence	recurrence	nn1
and	and	cc
the	the	at
other	other	jj_nn1@
a	a	at1
spinal	spinal	jj
cord	cord	nn1
metastasis	metastasis	nn1
.	.	y
Four	four	mc
of	of	io
the	the	at
6	6	mc
patients	patient	nn2
who	who	pnqs
received	receive	vvd
postoperative	postoperative	jj
radiotherapy	radiotherapy	nn1
were	be	vbdr
alive	alive	jj
at	at	ii
the	the	at
last	last	md
follow-up	follow-up	nn1
.	.	y
The	the	at
3	3	mc
patients	patient	nn2
who	who	pnqs
did	do	vdd
not	not	xx
undergo	undergo	vvi
adjuvant	adjuvant	jj_nn1
irradiation	irradiation	nn1
all	all	db_rr@
died	die	vvd_vvn@
of	of	io
a	a	at1
distant	distant	jj
metastasis	metastasis	nn1
.	.	y
Despite	despite	ii
aggressive	aggressive	jj
surgical	surgical	jj
treatment	treatment	nn1
and	and	cc
postoperative	postoperative	jj
radio-	radio-	nn1_jj
and	and	cc
chemotherapy	chemotherapy	nn1
,	,	y
primary	primary	jj_nn1
sinonasal	sinonasal	nn1_jj@
malignant	malignant	nn1_jj
melanoma	melanoma	nn1
carries	carry	vvz
a	a	at1
poor	poor	jj
prognosis	prognosis	nn1
.	.	y
All	all	db
9	9	mc
patients	patient	nn2
who	who	pnqs
were	be	vbdr
aggressively	aggressively	rr
treated	treat	vvn
developed	develop	vvn_jj_vvd
either	either	rr
a	a	at1
recurrence	recurrence	nn1
or	or	cc
a	a	at1
local	local	jj
or	or	cc
distant	distant	jj
metastasis	metastasis	nn1
.	.	y
One	one	mc1
of	of	io
the	the	at
drawbacks	drawback	nn2
of	of	io
this	this	dd1
study	study	nn1
obviously	obviously	rr
is	be	vbz
the	the	at
small	small	jj
size	size	nn1
of	of	io
the	the	at
patient	patient	jj_nn1
sample	sample	nn1
,	,	y
which	which	ddq
precluded	preclude	vvd
us	us	ppio2
from	from	ii
identifying	identify	vvg
statistically	statistically	rr
significant	significant	jj
differences	difference	nn2
.	.	y
However	however	rr
,	,	y
in	in	ii31
view	view	ii32
of	of	ii33
the	the	at
paucity	paucity	nn1
of	of	io
literature	literature	nn1
on	on	ii
sinonasal	sinonasal	nn1_jj@
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
to	to	to
add	add	vvi
to	to	ii
our	our	appge
knowledge	knowledge	nn1
of	of	io
this	this	dd1
disease	disease	nn1
,	,	y
its	its	z'
treatment	treatment	nn1
,	,	y
and	and	cc
its	its	z'
prognosis	prognosis	nn1
.	.	y
Table	table	nn1
.	.	y
Patient	patient	jj_nn1
data	data	nn
and	and	cc
summary	summary	nn1
of	of	io
findings	finding	nn2
pre-formatted	pre-formatted	zz
table	table	nn1
References	reference	nn2
(	(	y
n1	n1	fo
.	.	y
)	)	y
Weber	weber	np1
CO	co	np1_fo
.	.	y
Chirurgische		np1@
Ehrfahrungen		np1
und	und	np1
Untersuchungen	untersuchungen	np1
,	,	y
nebst	nebst	vv0_nn1
zahlreichen	zahlreichen	jj_nn1
Beobachtungen	beobachtungen	nn1_np1
aus	aus	nn2_fw
der	der	fu
chirurgischen	chirurgischen	jj_nn1
Klinik	klinik	nn1_np1
und	und	fw
dem	dem	fw
evangelischen	evangelischen	jj_nn1
Krahkenhause	krahkenhause	nn1_np1_vv0
zu	zu	fw
Bonn	bonn	np1
.	.	y
Berlin	berlin	np1
:	:	y
G.	g	np1
Reimer	reimer	np1_nn1
;	;	y
1859.	1859	mc
(	(	y
n2	n2	fo
.	.	y
)	)	y
Batsakis	batsakis	np1@
JG	jg	np1
,	,	y
Suarez	suarez	np1
P	xx_p	zz1_np1@
,	,	y
El-Naggar		np1
AK	ak	np1_nn1
.	.	y
Mucosal	mucosal	jj
melanomas	melanoma	nn2
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
.	.	y
Ann	ann	np1
Otol	otol	np1
Rhinol	rhinol	np1
Laryngol	laryngol	np1_nn1
1998	1998	mc
;	;	y
107(7):626-30.		fo
(	(	y
n3	n3	fo
.	.	y
)	)	y
Conley	conley	np1@
JJ	xx_jj	np1
.	.	y
Melanomas	melanoma	nn2
of	of	io
the	the	at
mucous	mucous	nn1
membrane	membrane	nn1
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
.	.	y
Laryngoscope	laryngoscope	nn1_np1@
1989	1989	mc
;	;	y
99(12):1248-54.		fo
(	(	y
n4	n4	fo
.	.	y
)	)	y
Moore	moore	np1
ES	es	np1_fw
,	,	y
Martin	martin	np1
H.	h	np1
Melanoma	melanoma	np1_nn1@
of	of	io
the	the	at
upper	upper	jj
respiratory	respiratory	jj
tract	tract	nn1
and	and	cc
oral	oral	jj_nn1
cavity	cavity	nn1
.	.	y
Cancer	cancer	nn1
1955	1955	mc
;	;	y
8(6):1167-76.		fo
(	(	y
n5	n5	fo
.	.	y
)	)	y
Shah	shah	np1
JP	jp	nna
,	,	y
Huvos		np1_nn2
AG	ag	fo
,	,	y
Strong	strong	jj_np1@
EW	ew	nn1_np1
.	.	y
Mucosal	mucosal	jj
melanomas	melanoma	nn2
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
.	.	y
Am	be	vbm
J	xx_j	np1@
Surg	surg	np1_nn1
1977	1977	mc
;	;	y
134(4):531-5.		fo
(	(	y
n6	n6	fo
.	.	y
)	)	y
Snow	snow	np1
GB	gb	np1
,	,	y
van	van	np1
der	der	np1
Esch	esch	np1
EP	ep	np1
,	,	y
van	van	np1
Slooten		np1
EA	ea	np1
.	.	y
Mucosal	mucosal	jj
melanomas	melanoma	nn2
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
.	.	y
Head	head	nn1_jj@_vv0@
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
1978	1978	mc
;	;	y
1(1):24-30.		fo
(	(	y
n7	n7	fo
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
melanoma	melanoma	nn1
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1_vv0@
:	:	y
Review	review	nn1
of	of	io
the	the	at
literature	literature	nn1
and	and	cc
report	report	nn1
of	of	io
14	14	mc
patients	patient	nn2
.	.	y
Cancer	cancer	nn1
1997	1997	mc
;	;	y
80(8):1373-86.		fo
(	(	y
n8	n8	fo
.	.	y
)	)	y
Hoyt	hoyt	vv0_nn1
DJ	dj	nn1
,	,	y
Jordan	jordan	np1
T	t	zz1_np1@
,	,	y
Fisher	fisher	np1
SR	sr	nna
.	.	y
Mucosal	mucosal	jj
melanoma	melanoma	nn1
of	of	io
the	the	at
head	head	nn1
and	and	cc
neck	neck	nn1
.	.	y
Arch	arch	jj_nn1
Otolaryngol	otolaryngol	nn1
Head	head	nn1
Neck	neck	nn1
Surg	surg	nn1_np1_vv0
1989	1989	mc
;	;	y
115(9):1096-9.		fo
(	(	y
n9	n9	fo
.	.	y
)	)	y
Ravid	ravid	np1@_jj
JM	jm	np1
,	,	y
Esteves	esteves	np1
JA	ja	np1_fw
.	.	y
Malignant	malignant	jj_nn1
melanoma	melanoma	nn1
of	of	io
the	the	at
nose	nose	nn1
and	and	cc
paranasal	paranasal	nn1_jj@
sinuses	sinus	nn2_vvz
and	and	cc
juvenile	juvenile	jj
melanoma	melanoma	nn1
of	of	io
the	the	at
nose	nose	nn1
.	.	y
Arch	arch	jj_nn1
Otolaryngol	otolaryngol	nn1_np1
1960	1960	mc
;	;	y
72:431-44.		mcmc
(	(	y
n10	n10	fo
.	.	y
)	)	y
Harrison	harrison	np1
DE	de	np1
Malignant	malignant	np1_jj_nn1
melanomata	melanomata	nn1
arising	arise	vvg
in	in	ii
the	the	at
nasal	nasal	jj
mucous	mucous	nn1
membrane	membrane	nn1
.	.	y
J	xx_j	np1@_zz1
Laryngol	laryngol	np1
Otol	otol	np1_nn1
1976	1976	mc
;	;	y
90(11):993-1005.		fo
(	(	y
n11	n11	fo
.	.	y
)	)	y
Prasad	prasad	nn1_np1@
ML	ml	nnu
,	,	y
Busam	busam	np1
KJ	kj	np1
,	,	y
Patel	patel	np1
SG	sg	np1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Clinicopathologic	clinicopathologic	jj
differences	difference	nn2
in	in	ii
malignant	malignant	jj_nn1
melanoma	melanoma	nn1
arising	arise	vvg
in	in	ii_rp@
oral	oral	jj
squamous	squamous	jj
and	and	cc
sinonasal	sinonasal	jj@_nn1
respiratory	respiratory	jj
mucosa	mucosa	nn1
of	of	io
the	the	at
upper	upper	jj
aerodigestive	aerodigestive	jj
tract	tract	nn1
.	.	y
Arch	arch	jj_nn1
Pathol	pathol	nn1
Lab	lab	nn1
Med	m	vvd@_jj
2003	2003	mc
;	;	y
127(8):997-1002		fo
.	.	y
By	by	ii
Sudesh		np1
Kumar	kumar	np1
,	,	y
MS	ms	nn1
,	,	y
DNB	dnb	np1
,	,	y
From	from	ii
the	the	at
Department	department	nn1
of	of	io
Otolaryngology-Head	otolaryngology-head	nn1
and	and	cc
Neck	neck	nn1_vv0@
Surgery	surgery	nn1
,	,	y
Postgraduate	postgraduate	nn1
Institute	institute	nn1
of	of	io
Medical	medical	jj
Education	education	nn1
and	and	cc
Research	research	nn1
,	,	y
Chandigarh	chandigarh	np1
,	,	y
India	india	np1
;	;	y
Ashok	ashok	np1
K.	k	np1
Gupta	gupta	np1
,	,	y
MS	ms	nn1
,	,	y
DLO	dlo	np1_nn1
,	,	y
MNAMS		np2
,	,	y
From	from	ii
the	the	at
Department	department	nn1
of	of	io
Otolaryngology-Head	otolaryngology-head	nn1
and	and	cc
Neck	neck	nn1_vv0@
Surgery	surgery	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
India	india	np1
;	;	y
Budhi		np1
S.	s	zz
Yadav	yadav	np1
,	,	y
BS	bs	np1
,	,	y
MD	md	nn1_np1@
,	,	y
Department	department	nn1
of	of	io
Radiotherapy	radiotherapy	np1_nn1
,	,	y
Postgraduate	postgraduate	nn1
Institute	institute	nn1
of	of	io
Medical	medical	jj
Education	education	nn1
and	and	cc
Research	research	nn1
,	,	y
Chandigarh	chandigarh	np1
,	,	y
India	india	np1
and	and	cc
Sushmita	sushmita	np1
Ghoshal	ghoshal	np1
,	,	y
MD	md	nna
,	,	y
DNB	dnb	np1
,	,	y
Department	department	nn1
of	of	io
Radiotherapy	radiotherapy	np1_nn1
,	,	y
Postgraduate	postgraduate	nn1
Institute	institute	nn1
of	of	io
Medical	medical	jj
Education	education	nn1
and	and	cc
Research	research	nn1
,	,	y
Chandigarh	chandigarh	np1
,	,	y
India	india	np1
Corresponding	corresponding	jj_vvg
author	author	nn1
:	:	y
Dr.	dr	nnb
Sudesh		np1
Kumar	kumar	np1
,	,	y
Department	department	nn1
of	of	io
Otolaryngology-Head	otolaryngology-head	nn1
and	and	cc
Neck	neck	nn1_vv0@
Surgery	surgery	nn1
,	,	y
Postgraduate	postgraduate	nn1
Institute	institute	nn1
of	of	io
Medical	medical	jj
Education	education	nn1
and	and	cc
Research	research	nn1
,	,	y
Chandigarh	chandigarh	np1
,	,	y
India	india	np1
160012	160012	mc
.	.	y
E-mail	e-mail	nn1_vv0@
:	:	y
**28;18671;TOOLONG		fo
or	or	cc
Sudeshkumar74@gmail.com		fo
